- Home
- LYG vs TAK Comparison
LYG vs TAK Comparison
Compare LYG & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYG
- TAK
- Stock Information
- Founded
- LYG 1695
- TAK 1781
- Country
- LYG United Kingdom
- TAK Japan
- Employees
- LYG N/A
- TAK N/A
- Industry
- LYG Commercial Banks
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- LYG Finance
- TAK Health Care
- Exchange
- LYG Nasdaq
- TAK Nasdaq
- Market Cap
- LYG 41.6B
- TAK 42.5B
- IPO Year
- LYG N/A
- TAK N/A
- Fundamental
- Price
- LYG $2.67
- TAK $13.12
- Analyst Decision
- LYG Buy
- TAK
- Analyst Count
- LYG 4
- TAK 0
- Target Price
- LYG $2.75
- TAK N/A
- AVG Volume (30 Days)
- LYG 9.7M
- TAK 1.8M
- Earning Date
- LYG 10-23-2024
- TAK 01-30-2025
- Dividend Yield
- LYG 5.52%
- TAK 4.76%
- EPS Growth
- LYG N/A
- TAK 49.73
- EPS
- LYG 0.09
- TAK 1.27
- Revenue
- LYG $24,874,681,670.00
- TAK $31,732,209,416.00
- Revenue This Year
- LYG N/A
- TAK $4.41
- Revenue Next Year
- LYG $4.77
- TAK $1.09
- P/E Ratio
- LYG $7.07
- TAK $20.89
- Revenue Growth
- LYG 7.75
- TAK 9.43
- 52 Week Low
- LYG $2.00
- TAK $12.58
- 52 Week High
- LYG $3.24
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- LYG 39.78
- TAK 35.28
- Support Level
- LYG $2.68
- TAK $13.46
- Resistance Level
- LYG $2.83
- TAK $13.42
- Average True Range (ATR)
- LYG 0.05
- TAK 0.15
- MACD
- LYG 0.01
- TAK -0.03
- Stochastic Oscillator
- LYG 11.11
- TAK 0.54
About LYG Lloyds Banking Group Plc
Lloyds is a retail and commercial bank headquartered in the United Kingdom. The bank operates via three business segments: retail, commercial banking, and insurance and wealth. In retail, Lloyds offers primarily mortgages (66% of loan portfolio), credit cards, and current accounts to its customers. Its commercial banking operation provides lending, transaction banking, working capital management, and debt capital market services to large companies and financial institutions in the UK Insurance and wealth rounds out the product lineup with life and property insurance as well as pension solutions and high-net-worth asset-management services.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.